Research from UK biostatisticians finds that PSA screening for prostate cancer poses a substantially greater risk of overdiagnosis in men over 70, while men tested before their mid-60s face relatively ...
A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...
Routine PSA testing is not recommend by the USPSTF for men 70 and older, a group expected to derive little benefit. Similar to trends in the U.S., this U.K. study found that a high number of older men ...
EDITOR’S NOTE: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. When I learned that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results